AgeneBio is developing AGB101, a Phase-3 ready candidate targeting a large unserved aMCI patient population. If approved, AGB101 will be the first and only therapeutic that targets hippocampus
The approved claims describe the device and components that are important for its function. As previously announced, Adamis acquired worldwide rights to the Taper DPI technology in all
"This is a significant milestone for our company," noted Karl Pinto, CEO of Goodwin Biotechnology. "We have been committed to investing in and advancing the field of Bioconjugation
Under the terms of a joint venture (JV) agreement between the parties, G-treeBNT will be responsible for conducting and funding all clinical trials and product development through approval
Fomepizole , an alcohol dehydrogenase inhibitor , is marketed and distributed by Paladin Labs Inc. ( "Paladin" ) in Canada and is the standard treatment for ethylene glycol
CRN, the leading trade association for the dietary supplement and functional food industry, developed these guidelines in response to recommendations from authoritative medical organizations, including the American Academy
Novel approaches to understanding the complex failures of the blood-brain-barrier that result in neurodegeneration are welcome. Innovation should lead to the cure therapies that do not exist today,
Together with the National Institute of Allergy and Infectious Diseases (NIAID), WCCT-Global is currently conducting influenza infection studies in healthy volunteers and is the first CRO to conduct
The patent is expected to expire no earlier than its twenty-year term in 2032. RayVa is the proprietary name for Apricus’ product candidate for the treatment of Raynaud’s
"With our serialization concept, we offer customers more than just a machine," explains Daniel Sanwald, product manager at Bosch Packaging Technology. "Bosch offers the complete package, which also
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.